We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIM icon
3001
Nuveen Select Maturities Municipal Fund
NIM
$116M
$174K ﹤0.01%
17,250
PHK
3002
PIMCO High Income Fund
PHK
$869M
$174K ﹤0.01%
+19,903
New +$174K
HYB
3003
DELISTED
New America High Income Fund, Inc.
HYB
$174K ﹤0.01%
+18,328
New +$175K
WNEB icon
3004
Western New England Bancorp
WNEB
$281M
$173K ﹤0.01%
17,055
+720
+4% +$7.42K
TVRD
3005
Tvardi Therapeutics
TVRD
$18.8M
$173K ﹤0.01%
+312
New +$198K
LTM
3006
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$173K ﹤0.01%
+15,604
New +$188K
ADP icon
3007
CALL
Automatic Data Processing
ADP
$107B
$171K ﹤0.01%
39,500
-5,000
-11% -$506K
CIE
3008
DELISTED
Cobalt International Energy, Inc
CIE
$168K ﹤0.01%
68,067
+60,158
+761% +$283K
PER
3009
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$167K ﹤0.01%
57,679
-8,885
-13% -$27K
AFL icon
3010
CALL
Aflac
AFL
$63.9B
$166K ﹤0.01%
139,000
+17,600
+14% +$661K
CVE icon
3011
Cenovus Energy
CVE
$51.1B
$166K ﹤0.01%
22,580
-858
-4% -$7.96K
TCON
3012
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$166K ﹤0.01%
+346
New +$211K
MFT
3013
DELISTED
BLACKROCK MUNIYIELD INVESTMENT QUALITY FUND
MFT
$166K ﹤0.01%
+11,800
New +$166K
RGP icon
3014
Resources Connection
RGP
$153M
$165K ﹤0.01%
+12,037
New +$164K
CBL
3015
DELISTED
CBL& Associates Properties, Inc.
CBL
$165K ﹤0.01%
19,531
+561
+3% +$4.82K
CB icon
3016
CALL
Chubb
CB
$136B
$164K ﹤0.01%
51,300
+7,000
+16% +$985K
GNW icon
3017
Genworth Financial
GNW
$3.71B
$164K ﹤0.01%
43,459
-74,928
-63% -$284K
BSF
3018
DELISTED
Bear State Financial, Inc.
BSF
$163K ﹤0.01%
17,199
+1,277
+8% +$11.8K
ESCA icon
3019
Escalade
ESCA
$307M
$162K ﹤0.01%
+12,359
New +$156K
PGTI
3020
DELISTED
PGT, Inc.
PGTI
$161K ﹤0.01%
12,609
+281
+2% +$3.22K
ERF
3021
DELISTED
Enerplus Corporation
ERF
$160K ﹤0.01%
19,665
+103
+0.5% +$813
UNP icon
3022
CALL
Union Pacific
UNP
$176B
$159K ﹤0.01%
97,000
+52,100
+116% +$5.68M
VIPS icon
3023
Vipshop
VIPS
$7.46B
$159K ﹤0.01%
+15,085
New +$197K
PSP icon
3024
Invesco Global Listed Private Equity ETF
PSP
$245M
$158K ﹤0.01%
2,540
+286
+13% +$17.6K
WPRT
3025
Westport Fuel Systems
WPRT
$35.5M
$158K ﹤0.01%
6,739
+400
+6% +$6.24K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.